Rock Point Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Other funds holding NVO
F
Rock Point Advisors's NVO Position: Q2 2026 in Review
Rock Point Advisors held its Novo Nordisk (NVO) position steady in Q2 2026 at 6,700 shares worth $321K. The position accounts for 0.08% of the portfolio, ranked #95.
Rock Point Advisors first reported a position in NVO in Q4 2019 and has held it in 27 quarters since. The position peaked at $1.01M in Q2 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Rock Point Advisors held 6,700 shares of Novo Nordisk worth $321K as of Q2 2026.
- Rock Point Advisors left its Novo Nordisk share count unchanged in Q2 2026.
- Novo Nordisk made up 0.08% of Rock Point Advisors's portfolio in Q2 2026, its #95 holding.
- Rock Point Advisors first reported a position in Novo Nordisk in Q4 2019 and has held it in 27 quarters since.
- Rock Point Advisors's Novo Nordisk position peaked at $1.01M in Q2 2024.
- 1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Rock Point Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.